CRISPR Gene Editing Newsletter
Issue #9November 3, 20257 studies

Gene editing gets a major upgrade with retrons, plus CRISPR tackles cancer and crops

Gene editing gets a major upgrade with retrons, plus CRISPR tackles cancer and crops

Monday, November 3rd CRISPR Gene Editing Newsletter Issue #9

This week brought breakthrough advances in precision gene editing, from ancient bacterial systems that could revolutionize medicine to new ways of fighting cancer and improving crops. Here's what caught our attention.

🧬 Ancient Bacterial Systems Could Transform Gene Editing

Scientists have engineered retrons—ancient bacterial DNA-making systems—into powerful new gene editors that rival traditional methods. These systems can produce multiple copies of single-stranded DNA inside cells and achieve editing efficiency comparable to conventional methods but from genetically encoded instructions.

  • The engineered retron editors work with both Cas12a and Cas9 systems, expanding what genes can be targeted without needing to break both DNA strands

  • Researchers successfully used retrons to add a split GFP tag for live-cell imaging, proving they can insert useful genetic cargo

  • The team developed an all-RNA delivery method that enables DNA-free gene editing in both cells and live vertebrate embryos

Why this matters: Retrons could solve major gene editing challenges by providing a safer, more versatile way to make precise genetic changes without the risks of double-strand DNA breaks.

🏆 Top 0.1% journal 🔗 Nature Biotechnology 🗓️ Oct 23

Key Findings

🎯 All-RNA Platform Reprograms T Cells Without DNA Damage

Researchers developed an all-RNA system that can turn genes on or off in immune T cells using CRISPRoff and CRISPRon editors. The platform avoids the safety risks of traditional gene editing by not breaking DNA strands, while still maintaining changes through multiple cell divisions and T cell activations. When combined with CAR-T cell therapy targeting cancer, the dual genetic and epigenetic approach improved tumor control and survival in preclinical studies.

💡 Programming T cells without DNA breaks could make cancer immunotherapy safer and more effective.
🏆 Top 0.1% journal 🔗 Nature Biotechnology 🗓️ Oct 21

🔬 20-Minute Test Identifies Food Poisoning Bacteria

Scientists created a rapid detection system that can identify all seven types of Clostridium perfringens (a major food poisoning cause) in just 20 minutes at 34°C. The CRISPR/Cas12a-based test achieved detection limits of ≤10 copies/μL across all targets while maintaining perfect specificity. When tested on 12 naturally contaminated food samples, it accurately identified 8 Type A and 4 Type F strains, outperforming commercial qPCR kits.

💡 Portable 20-minute bacterial detection could revolutionize food safety monitoring in resource-limited settings.
Top 20% journal 🔗 Talanta 🗓️ Oct 24

🌱 Walnut Genome Editing Platform Achieves 58% Success Rate

Researchers developed an optimized CRISPR/Cas9 system for walnuts by screening 30 cultivars and identifying native promoters that dramatically boost editing efficiency. The HT-14 walnut cultivar showed the highest embryo formation (53.33%) and regeneration rates (85.33%). Most importantly, native walnut promoters achieved 58.82% editing efficiency—significantly higher than commonly used external promoters—while promoting more complete mutations.

💡 Using species-specific promoters could unlock precision breeding in other economically important tree crops.
🥉 Top 5% journal 🔗 Horticulture Research 🗓️ Oct 23

🧪 Gene Editing Reveals New Cancer Drug Target

CRISPR studies showed that deleting the MNT gene significantly extends survival in mouse models of acute myeloid leukemia, with 50% of mice becoming leukemia-free. The research demonstrated that MNT deletion makes both mouse and human AML cells more sensitive to existing cancer drugs called BH3 mimetics. In human AML cell lines transplanted into mice, MNT deletion reduced tumor burden and significantly extended survival.

💡 MNT could be a valuable new drug target for both blood cancers and solid tumors.
🔗 Blood neoplasia 🗓️ Oct 27

🦠 CRISPR Reveals How Viruses Hijack Cell Defenses

Using CRISPR knockouts in zebrafish, scientists discovered that deleting mk2b and mk3 genes makes fish significantly more susceptible to chikungunya virus infection. The mk3 knockout showed the greatest vulnerability, while mk2b knockouts had reduced TNF-α expression, suggesting higher TNF-α levels help clear viruses through the p38-MK2-TNF-α pathway. All knockout fish showed higher viral loads and stronger immune responses with increased interferon and antiviral gene expression.

💡 Understanding how viruses exploit cellular stress pathways could lead to new antiviral treatments.
🎖️ Top 10% journal 🔗 FASEB Journal 🗓️ Oct 21

🔬 Forensic Body Fluid ID Gets 40-Minute Upgrade

A new CRISPR-based system can identify five different types of forensic evidence—blood, menstrual blood, vaginal secretion, semen, and saliva—in under 40 minutes. The platform achieved detection sensitivity as low as 0.1 ng for most markers and successfully analyzed mixed samples and aged specimens. The system works with portable devices, making it suitable for crime scene analysis without laboratory infrastructure.

💡 Rapid on-site forensic analysis could transform criminal investigations and evidence processing.
Top 20% journal 🔗 Forensic Science International: Genetics 🗓️ Oct 24

Implications

These advances show CRISPR technology maturing beyond basic gene editing into sophisticated platforms for medicine, agriculture, and forensics. The shift toward safer RNA-based approaches and species-optimized systems suggests we're entering a new phase where gene editing becomes more precise, accessible, and practical for real-world applications.

Studies in this issue

Primary sources used for this newsletter.

  1. Using and Improving Retrons for Accurate Genome Editing
    main storyNature biotechnology2025-10-23PMID 41131151
  2. Two rapid tests using CRISPR technology to identify five types of forensic body fluids
    key findingForensic science international. Genetics2025-10-24PMID 41135303
  3. Combined genetic and epigenetic regulation of human primary T cells
    key findingNature biotechnology2025-10-21PMID 41120666
  4. Targeting MNT for Better Treatment of Acute Myeloid Leukemia
    key findingBlood neoplasia2025-10-27PMID 41140443
  5. Mutations in Two Host Proteins Increase Chikungunya Virus Sensitivity and Change Immune Responses in Zebrafish
    key findingFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025-10-21PMID 41117602